CAPPA new SSPC collaborator

Share on facebook
Share on google
Share on twitter
Share on linkedin

The Centre for Advanced Photonics & Process Analysis (CAPPA) is now an official SSPC collaborator. SSPC’s new research programme focuses on five main topics: molecule, materials, medicine, manufacturing and modelling. Research with CAPPA will fall within the medicine theme.

CAPPA

CAPPA has over 13 years’ experience in working with companies in the pharmaceutical sector. In the pharmaceutical sector CAPPA focuses on various areas including product analysis, product stability monitoring, process monitoring, quality control and packaging. CAPPA have worked with various pharmaceutical companies over the years including Janssen, Astellas, Sepha, Biocel and Hooke Bio. Photonics provides a range of invaluable solutions to the pharmaceutical industry. CAPPA have worked with photonics in the pharmaceuticals industry to investigate areas such as drug identification, blend uniformity, chemometrics, monitoring phase changes, cleaning verification, root cause analysis of contaminants, particle size analysis of powders and anti – counterfeit measures for packaging. CAPPA has been heavily involved in research for focusing on the development and deployment of Process Analytical Technologies (PAT), a major priority within the industry currently, and has applications inline, at – line and offline.

For any funding enquiries please contact donal.killackey@sspc.ie.

Source: www.cappa.ie

 

Related News

Paper published by SSPC at University College Dublin

Paper published by SSPC at University College Dublin

Melba et al. based at University College Dublin published a paper in Chemical…

  • November 21, 2018
Eva Philbin Public Lecture Series with SSPC Co-Principal Investigator Prof. Anita Maguire

Eva Philbin Public Lecture Series with SSPC Co-Principal Investigator Prof. Anita Maguire

In conjunction with SSPC Technical Meeting being held in the Joly Lecture Theatre,…

  • November 27, 2018

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.